Prognostic Factor and Clinical Outcome in Stage III Non–Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population

PURPOSE: The optimal treatment for patients with stage III non–small cell lung cancer (NSCLC) remains controversial. This study aimed to investigate prognostic factors and clinical outcome in stage III NSCLC using real-world clinical data in the Korean population. MATERIALS AND METHODS: Among 8,110...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ho Cheol, Ji, Wonjun, Lee, Jae Cheol, Kim, Hyeong Ryul, Song, Si Yeol, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524024/
https://www.ncbi.nlm.nih.gov/pubmed/33592139
http://dx.doi.org/10.4143/crt.2020.1350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524024/
https://www.ncbi.nlm.nih.gov/pubmed/33592139
http://dx.doi.org/10.4143/crt.2020.1350

Ejemplares similares